Impact of the Inflation Reduction Act on real-world evidence: an interview with Amanda Cole, Office of Health Economics

Written by Amanda Cole (Office of Health Economics)
Health economics Health policy Health technology assessment Interviews Market access Medical devices, pharmaceuticals and vaccines Real-world evidence Value assessment

Continuing our interview series with experts discussing the impact of the Inflation Reduction Act (IRA), we speak with Amanda Cole, Associate Director at the Office of Health Economics about the opportunity for the IRA to advance real-world evidence (RWE) in the US. Please could you introduce yourself and your organization? I’m Amanda Cole and lead the Economics of Innovation team at the Office of Health Economics (OHE). OHE is an independent research organization and UK-headquartered non-profit working on global health economics policy issues primarily within the life sciences sector, and is the world’s oldest health economics research institute. The IRA...

To view this content, please register now for access

It's completely free